These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 8554734

  • 1. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats.
    Freeman EJ, Ferrario CM, Tallant EA.
    Am J Hypertens; 1995 Nov; 8(11):1105-11. PubMed ID: 8554734
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR.
    Andresen BT, Jackson EK, Romero GG.
    Hypertension; 2001 Feb; 37(2 Pt 2):635-9. PubMed ID: 11230348
    [Abstract] [Full Text] [Related]

  • 3. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.
    Freeman EJ, Tallant EA.
    Biochem J; 1994 Dec 01; 304 ( Pt 2)(Pt 2):543-8. PubMed ID: 7998990
    [Abstract] [Full Text] [Related]

  • 4. AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cells.
    Andresen BT, Romero GG, Jackson EK.
    J Pharmacol Exp Ther; 2004 Apr 01; 309(1):425-31. PubMed ID: 14722318
    [Abstract] [Full Text] [Related]

  • 5. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats.
    Rosen B, Barg J, Zimlichman R.
    Am J Hypertens; 1999 Dec 01; 12(12 Pt 1-2):1243-51. PubMed ID: 10619588
    [Abstract] [Full Text] [Related]

  • 6. Role of calcium and protein kinase C in the activation of phospholipase D by angiotensin II in vascular smooth muscle cells.
    Freeman EJ, Chisolm GM, Tallant EA.
    Arch Biochem Biophys; 1995 May 10; 319(1):84-92. PubMed ID: 7771808
    [Abstract] [Full Text] [Related]

  • 7. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A, Kanmatsuse K.
    J Hypertens; 1999 Aug 10; 17(8):1099-107. PubMed ID: 10466465
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats.
    Kim HY, Kang YJ, Song IH, Choi HC, Kim HS.
    Hypertens Res; 2008 Mar 10; 31(3):515-23. PubMed ID: 18497472
    [Abstract] [Full Text] [Related]

  • 9. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II.
    Fukuda N, Hu WY, Kubo A, Endoh M, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K.
    Hypertension; 1998 Feb 10; 31(2):672-7. PubMed ID: 9461239
    [Abstract] [Full Text] [Related]

  • 10. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Satoh C, Hu WY, Soma M, Kubo A, Kishioka H, Watanabe Y, Izumi Y, Kanmatsuse K.
    Arterioscler Thromb Vasc Biol; 1999 May 10; 19(5):1210-7. PubMed ID: 10323771
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D.
    Li F, Malik KU.
    J Pharmacol Exp Ther; 2005 Mar 10; 312(3):1043-54. PubMed ID: 15525798
    [Abstract] [Full Text] [Related]

  • 12. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats.
    Satoh C, Fukuda N, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K.
    J Cardiovasc Pharmacol; 2001 Jan 10; 37(1):108-18. PubMed ID: 11152368
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats.
    Kubo A, Fukuda N, Soma M, Izumi Y, Kanmatsuse K.
    J Cardiovasc Pharmacol; 1996 Jan 10; 27(1):58-63. PubMed ID: 8656659
    [Abstract] [Full Text] [Related]

  • 14. The Ang II-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism.
    Freeman EJ.
    Arch Biochem Biophys; 2000 Feb 15; 374(2):363-70. PubMed ID: 10666319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ca(2+)-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype.
    Lucchesi PA, Bell JM, Willis LS, Byron KL, Corson MA, Berk BC.
    Circ Res; 1996 Jun 15; 78(6):962-70. PubMed ID: 8635246
    [Abstract] [Full Text] [Related]

  • 17. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Hu WY, Teng J, Chikara S, Nakayama M, Kishioka H, Kanmatsuse K.
    Atherosclerosis; 2002 Aug 15; 163(2):229-39. PubMed ID: 12052469
    [Abstract] [Full Text] [Related]

  • 18. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1.
    Touyz RM, Tolloczko B, Schiffrin EL.
    J Hypertens; 1994 Jun 15; 12(6):663-73. PubMed ID: 7963491
    [Abstract] [Full Text] [Related]

  • 19. Enhanced expression of Gqα and PLC-β1 proteins contributes to vascular smooth muscle cell hypertrophy in SHR: role of endogenous angiotensin II and endothelin-1.
    Atef ME, Anand-Srivastava MB.
    Am J Physiol Cell Physiol; 2014 Jul 01; 307(1):C97-106. PubMed ID: 24760983
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.